Home / Conivaptan / United States
US ATC C03XA02 · updated 2 Nov 2026
Conivaptan shortage in United States
Is there a Conivaptan shortage in United States?
Yes. As of 2 Nov 2026, 1 Conivaptan product is reported short in United States, the first since 14 Mar 2022. No return date has been given. Main reason: distribution or logistics.
Not reported short in any other country we track. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10) | Cumberland Pharmaceuticals Inc. | 14 Mar 2022 | not given | Distribution or logistics Delay in shipping of the drug |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).